Your browser is no longer supported. Please, upgrade your browser.
Harrow Health, Inc.
Index- P/E36.36 EPS (ttm)0.26 Insider Own6.20% Shs Outstand26.74M Perf Week0.00%
Market Cap264.58M Forward P/E30.91 EPS next Y0.31 Insider Trans12.32% Shs Float23.92M Perf Month0.32%
Income7.10M PEG2.42 EPS next Q-0.03 Inst Own51.60% Short Float4.16% Perf Quarter-8.49%
Sales62.60M P/S4.23 EPS this Y0.00% Inst Trans-9.37% Short Ratio4.46 Perf Half Y42.92%
Book/sh0.87 P/B10.91 EPS next Y307.70% ROA10.10% Target Price15.13 Perf Year71.30%
Cash/sh3.05 P/C3.12 EPS next 5Y15.00% ROE27.20% 52W Range4.65 - 11.24 Perf YTD38.34%
Dividend- P/FCF29.40 EPS past 5Y40.00% ROI0.70% 52W High-15.57% Beta0.93
Dividend %- Quick Ratio11.00 Sales past 5Y38.10% Gross Margin74.70% 52W Low104.09% ATR0.52
Employees125 Current Ratio11.50 Sales Q/Q123.50% Oper. Margin19.80% RSI (14)48.57 Volatility4.91% 5.35%
OptionableYes Debt/Eq3.07 EPS Q/Q- Profit Margin11.30% Rel Volume0.29 Prev Close9.49
ShortableYes LT Debt/Eq3.07 EarningsAug 10 AMC Payout0.00% Avg Volume223.45K Price9.49
Recom1.50 SMA20-3.77% SMA503.19% SMA20013.56% Volume0 Change0.00%
Sep-24-21Initiated Aegis Capital Buy $15
Jul-02-21Initiated Ladenburg Thalmann Buy $14.25
Sep-27-21 08:26AM  
Sep-02-21 08:00AM  
Aug-18-21 07:00AM  
Aug-13-21 01:21AM  
Aug-12-21 12:45PM  
Aug-10-21 05:15PM  
Aug-05-21 10:57AM  
Aug-03-21 03:01PM  
Aug-02-21 05:50PM  
Jul-28-21 11:30AM  
Jul-27-21 07:00AM  
Jul-26-21 09:00AM  
Jul-19-21 08:00AM  
Jul-16-21 10:00AM  
Jul-15-21 08:00AM  
Jul-06-21 08:27AM  
Jun-23-21 06:34AM  
Jun-17-21 04:01PM  
Jun-14-21 05:59PM  
Jun-04-21 04:03AM  
Jun-03-21 08:15AM  
Jun-01-21 09:00AM  
May-17-21 09:00AM  
May-11-21 04:01PM  
May-05-21 04:03PM  
May-04-21 03:00PM  
Apr-27-21 09:00AM  
Apr-20-21 04:01PM  
Apr-15-21 05:00PM  
Apr-14-21 04:01PM  
Apr-05-21 05:43AM  
Mar-11-21 09:45AM  
Mar-08-21 06:05PM  
Mar-02-21 09:00AM  
Mar-01-21 04:26PM  
Feb-25-21 09:00AM  
Feb-09-21 07:00AM  
Feb-04-21 02:25AM  
Dec-18-20 11:22AM  
Dec-17-20 10:30AM  
Dec-15-20 10:30PM  
Dec-08-20 08:33AM  
Dec-03-20 07:30AM  
Nov-20-20 07:30AM  
Nov-09-20 05:35PM  
Nov-06-20 10:21AM  
Nov-02-20 12:31PM  
Oct-27-20 07:30AM  
Sep-30-20 08:00AM  
Sep-16-20 08:36AM  
Sep-11-20 11:22AM  
Sep-07-20 03:03PM  
Aug-26-20 08:16AM  
Aug-10-20 08:05PM  
Aug-07-20 11:05AM  
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
Jul-27-20 07:30AM  
Jul-24-20 10:24AM  
Jul-13-20 07:30AM  
Jun-30-20 11:57PM  
Jun-29-20 07:30AM  
Jun-24-20 08:30AM  
Jun-18-20 07:30AM  
May-14-20 08:40AM  
May-11-20 06:55PM  
May-05-20 08:52AM  
Apr-27-20 07:30AM  
Mar-24-20 07:30AM  
Mar-17-20 07:30AM  
Mar-13-20 11:15AM  
Mar-12-20 09:29AM  
Mar-09-20 07:30AM  
Mar-06-20 12:30PM  
Mar-03-20 07:30AM  
Feb-27-20 07:30AM  
Feb-03-20 09:24AM  
Jan-27-20 11:34AM  
Dec-16-19 07:35AM  
Dec-12-19 07:40AM  
Dec-10-19 07:40PM  
Nov-13-19 06:55PM  
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and Visionology, a membership-based online eye health and medication platform. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LINDSTROM RICHARD L MDDirectorSep 16Sale9.025,84052,67770,000Sep 17 05:15 PM
LINDSTROM RICHARD L MDDirectorSep 15Sale9.0914,160128,71475,840Sep 17 05:15 PM
Opaleye Management Inc.10% OwnerAug 19Buy8.4552,500443,3623,135,000Aug 23 05:59 PM
Opaleye Management Inc.10% OwnerAug 18Buy8.6446,500401,9793,085,000Aug 19 07:10 PM
Opaleye Management Inc.10% OwnerAug 17Buy8.5726,000222,7193,040,000Aug 19 07:10 PM
Opaleye Management Inc.10% OwnerJul 21Buy7.609,20669,9333,015,000Jul 22 09:19 AM
Opaleye Management Inc.10% OwnerJul 20Buy7.204,92535,4603,010,500Jul 22 09:19 AM
Opaleye Management Inc.10% OwnerJul 19Buy6.975,86940,8973,005,700Jul 22 09:19 AM
Opaleye Management Inc.10% OwnerJun 18Buy8.3563,322528,6883,000,000Jun 22 11:44 AM
Opaleye Management Inc.10% OwnerJun 17Buy8.3211,26293,7012,940,200Jun 22 11:44 AM
LINDSTROM RICHARD L MDDirectorMay 20Sale10.7510,000107,50090,000May 21 05:28 PM
BOLL ANDREW R.Chief Financial OfficerApr 25Option Exercise0.00127,5000273,000Apr 27 05:30 PM
BAUM MARK LChief Executive OfficerApr 25Option Exercise0.00850,00001,687,676Apr 27 05:29 PM
Opaleye Management Inc.10% OwnerDec 22Buy5.1916,55786,0102,929,400Dec 22 06:09 PM
Opaleye Management Inc.10% OwnerDec 21Buy5.2453,459280,0932,913,500Dec 22 06:09 PM
Opaleye Management Inc.10% OwnerDec 18Buy5.3136,400193,3792,862,100Dec 22 06:09 PM
Principi AnthonyDirectorSep 28Option Exercise0.0093,798093,798Sep 30 06:52 PM